Global Bile Duct Cancer Drug Sales Market Report 2018

Published On: Dec 2018

Format: PDF

Publisher: QY Research

Pages: 118

Report ID: 210664

This report studies the global Bile Duct Cancer Drug market status and forecast, categorizes the global Bile Duct Cancer Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

In 2017, the global Bile Duct Cancer Drug market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025.

The major players covered in this report
Ariad Pharmaceuticals, Inc.
ArQule, Inc.
Array BioPharma Inc.
Arrien Pharmaceuticals, LLC
Aslan Pharmaceuticals Pte. Ltd.
Bavarian Nordic A/S
Bayer AG
Blueprint Medicines Corporation
Boehringer Ingelheim GmbH
Boston Biomedical, Inc.
Bristol-Myers Squibb Company
Celgene Corporation
CellAct Pharma GmbH
Cellceutix Corporation
Cellular Biomedicine Group, Inc.
Concordia Healthcare Corp.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

The regional scope of the study is as follows:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Cabozantinib S-malate
Elpamotide
Exatecan Mesylate
LY-2801653
NUC-1031
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Clinic
Others

The study objectives of this report are:
To analyze and study the global Bile Duct Cancer Drug sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Bile Duct Cancer Drug players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Bile Duct Cancer Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Bile Duct Cancer Drug Manufacturers
Bile Duct Cancer Drug Distributors/Traders/Wholesalers
Bile Duct Cancer Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Bile Duct Cancer Drug market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global Bile Duct Cancer Drug Sales Market Report 2018
1 Bile Duct Cancer Drug Market Overview
1.1 Product Overview and Scope of Bile Duct Cancer Drug
1.2 Classification of Bile Duct Cancer Drug by Product Category
1.2.1 Global Bile Duct Cancer Drug Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Bile Duct Cancer Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Cabozantinib S-malate
1.2.4 Elpamotide
1.2.5 Exatecan Mesylate
1.2.6 LY-2801653
1.2.7 NUC-1031
1.2.8 Others
1.3 Global Bile Duct Cancer Drug Market by Application/End Users
1.3.1 Global Bile Duct Cancer Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Bile Duct Cancer Drug Market by Region
1.4.1 Global Bile Duct Cancer Drug Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Bile Duct Cancer Drug Status and Prospect (2013-2025)
1.4.3 Europe Bile Duct Cancer Drug Status and Prospect (2013-2025)
1.4.4 China Bile Duct Cancer Drug Status and Prospect (2013-2025)
1.4.5 Japan Bile Duct Cancer Drug Status and Prospect (2013-2025)
1.4.6 Southeast Asia Bile Duct Cancer Drug Status and Prospect (2013-2025)
1.4.7 India Bile Duct Cancer Drug Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Bile Duct Cancer Drug (2013-2025)
1.5.1 Global Bile Duct Cancer Drug Sales and Growth Rate (2013-2025)
1.5.2 Global Bile Duct Cancer Drug Revenue and Growth Rate (2013-2025)

2 Global Bile Duct Cancer Drug Competition by Players/Suppliers, Type and Application
2.1 Global Bile Duct Cancer Drug Market Competition by Players/Suppliers
2.1.1 Global Bile Duct Cancer Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Bile Duct Cancer Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Bile Duct Cancer Drug (Volume and Value) by Type
2.2.1 Global Bile Duct Cancer Drug Sales and Market Share by Type (2013-2018)
2.2.2 Global Bile Duct Cancer Drug Revenue and Market Share by Type (2013-2018)
2.3 Global Bile Duct Cancer Drug (Volume and Value) by Region
2.3.1 Global Bile Duct Cancer Drug Sales and Market Share by Region (2013-2018)
2.3.2 Global Bile Duct Cancer Drug Revenue and Market Share by Region (2013-2018)
2.4 Global Bile Duct Cancer Drug (Volume) by Application

3 United States Bile Duct Cancer Drug (Volume, Value and Sales Price)
3.1 United States Bile Duct Cancer Drug Sales and Value (2013-2018)
3.1.1 United States Bile Duct Cancer Drug Sales and Growth Rate (2013-2018)
3.1.2 United States Bile Duct Cancer Drug Revenue and Growth Rate (2013-2018)
3.1.3 United States Bile Duct Cancer Drug Sales Price Trend (2013-2018)
3.2 United States Bile Duct Cancer Drug Sales Volume and Market Share by Players (2013-2018)
3.3 United States Bile Duct Cancer Drug Sales Volume and Market Share by Type (2013-2018)
3.4 United States Bile Duct Cancer Drug Sales Volume and Market Share by Application (2013-2018)

4 Europe Bile Duct Cancer Drug (Volume, Value and Sales Price)
4.1 Europe Bile Duct Cancer Drug Sales and Value (2013-2018)
4.1.1 Europe Bile Duct Cancer Drug Sales and Growth Rate (2013-2018)
4.1.2 Europe Bile Duct Cancer Drug Revenue and Growth Rate (2013-2018)
4.1.3 Europe Bile Duct Cancer Drug Sales Price Trend (2013-2018)
4.2 Europe Bile Duct Cancer Drug Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Bile Duct Cancer Drug Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Bile Duct Cancer Drug Sales Volume and Market Share by Application (2013-2018)

5 China Bile Duct Cancer Drug (Volume, Value and Sales Price)
5.1 China Bile Duct Cancer Drug Sales and Value (2013-2018)
5.1.1 China Bile Duct Cancer Drug Sales and Growth Rate (2013-2018)
5.1.2 China Bile Duct Cancer Drug Revenue and Growth Rate (2013-2018)
5.1.3 China Bile Duct Cancer Drug Sales Price Trend (2013-2018)
5.2 China Bile Duct Cancer Drug Sales Volume and Market Share by Players (2013-2018)
5.3 China Bile Duct Cancer Drug Sales Volume and Market Share by Type (2013-2018)
5.4 China Bile Duct Cancer Drug Sales Volume and Market Share by Application (2013-2018)

6 Japan Bile Duct Cancer Drug (Volume, Value and Sales Price)
6.1 Japan Bile Duct Cancer Drug Sales and Value (2013-2018)
6.1.1 Japan Bile Duct Cancer Drug Sales and Growth Rate (2013-2018)
6.1.2 Japan Bile Duct Cancer Drug Revenue and Growth Rate (2013-2018)
6.1.3 Japan Bile Duct Cancer Drug Sales Price Trend (2013-2018)
6.2 Japan Bile Duct Cancer Drug Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Bile Duct Cancer Drug Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Bile Duct Cancer Drug Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Bile Duct Cancer Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Bile Duct Cancer Drug Sales and Value (2013-2018)
7.1.1 Southeast Asia Bile Duct Cancer Drug Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Bile Duct Cancer Drug Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Bile Duct Cancer Drug Sales Price Trend (2013-2018)
7.2 Southeast Asia Bile Duct Cancer Drug Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Bile Duct Cancer Drug Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Bile Duct Cancer Drug Sales Volume and Market Share by Application (2013-2018)

8 India Bile Duct Cancer Drug (Volume, Value and Sales Price)
8.1 India Bile Duct Cancer Drug Sales and Value (2013-2018)
8.1.1 India Bile Duct Cancer Drug Sales and Growth Rate (2013-2018)
8.1.2 India Bile Duct Cancer Drug Revenue and Growth Rate (2013-2018)
8.1.3 India Bile Duct Cancer Drug Sales Price Trend (2013-2018)
8.2 India Bile Duct Cancer Drug Sales Volume and Market Share by Players (2013-2018)
8.3 India Bile Duct Cancer Drug Sales Volume and Market Share by Type (2013-2018)
8.4 India Bile Duct Cancer Drug Sales Volume and Market Share by Application (2013-2018)

9 Global Bile Duct Cancer Drug Players/Suppliers Profiles and Sales Data
9.1 Ariad Pharmaceuticals, Inc.
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Bile Duct Cancer Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 ArQule, Inc.
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Bile Duct Cancer Drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 ArQule, Inc. Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Array BioPharma Inc.
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Bile Duct Cancer Drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Array BioPharma Inc. Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Arrien Pharmaceuticals, LLC
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Bile Duct Cancer Drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Aslan Pharmaceuticals Pte. Ltd.
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Bile Duct Cancer Drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Bavarian Nordic A/S
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Bile Duct Cancer Drug Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Bavarian Nordic A/S Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Bayer AG
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Bile Duct Cancer Drug Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Bayer AG Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Blueprint Medicines Corporation
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Bile Duct Cancer Drug Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Blueprint Medicines Corporation Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Boehringer Ingelheim GmbH
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Bile Duct Cancer Drug Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Boehringer Ingelheim GmbH Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Boston Biomedical, Inc.
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Bile Duct Cancer Drug Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Boston Biomedical, Inc. Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Bristol-Myers Squibb Company
9.12 Celgene Corporation
9.13 CellAct Pharma GmbH
9.14 Cellceutix Corporation
9.15 Cellular Biomedicine Group, Inc.
9.16 Concordia Healthcare Corp.

10 Bile Duct Cancer Drug Maufacturing Cost Analysis
10.1 Bile Duct Cancer Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Bile Duct Cancer Drug
10.3 Manufacturing Process Analysis of Bile Duct Cancer Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Bile Duct Cancer Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Bile Duct Cancer Drug Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Bile Duct Cancer Drug Market Forecast (2018-2025)
14.1 Global Bile Duct Cancer Drug Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Bile Duct Cancer Drug Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Bile Duct Cancer Drug Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Bile Duct Cancer Drug Price and Trend Forecast (2018-2025)
14.2 Global Bile Duct Cancer Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Bile Duct Cancer Drug Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Bile Duct Cancer Drug Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Bile Duct Cancer Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Bile Duct Cancer Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Bile Duct Cancer Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Bile Duct Cancer Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Bile Duct Cancer Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Bile Duct Cancer Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Bile Duct Cancer Drug Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Bile Duct Cancer Drug Sales Forecast by Type (2018-2025)
14.3.2 Global Bile Duct Cancer Drug Revenue Forecast by Type (2018-2025)
14.3.3 Global Bile Duct Cancer Drug Price Forecast by Type (2018-2025)
14.4 Global Bile Duct Cancer Drug Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer